Son of sevenless 1 (SOS1) is a Ras-specific guanine-nucleotideexchange factor (GEF) that mediates intracellular signaling processes induced by receptor tyrosine kinases. In this study, we show that CIIA (also known as VPS28) physically associates with SOS1 and thereby inhibits the GEF activity of SOS1 on Ras, which prevents the epidermal growth factor (EGF)-induced activation of the Ras-Erk1/2 pathway. Furthermore, CIIA inhibited cyclin D1 expression, as well as DNA, synthesis in response to EGF. Intriguingly, CIIA failed to inhibit the Ras-specific GEF activity of Noonan-syndrome-associated SOS1 mutants (M269R, R552G, W729L and E846K). Taken together, our results suggest that CIIA functions as a negative modulator of the SOS1-Ras signaling events initiated by peptide growth factors including EGF.
INTRODUCTION
Small GTPases play a pivotal role in intracellular signaling processes initiated by ligand-bound receptor tyrosine kinases (RTKs), which mediate diverse cellular activities, including cell proliferation and differentiation (Scita et al., 2000) . Activities of small GTPases are regulated by cycling between inactive GDPand active GTP-bound states, and this regulation is achieved by guanine-nucleotide-exchange factors (GEFs), GTPase-activating proteins (GAPs), and guanine-nucleotide-dissociation inhibitors (GDIs). Son of sevenless 1 (SOS1) is a dual GEF for the Ras and Rac1 GTPases (Nimnual et al., 1998) . SOS1 consists of two tandem histone fold (HF) domain, a diffuse B cell lymphoma homology (DH) domain, and a pleckstrin homology (PH) domain in the N-terminal region, a Ras-binding region (REM domain) and a Ras catalytic domain (Cdc25 domain) in the central region, and a proline-rich domain in the C-terminal region (Bar-Sagi, 1994; Corbalan-Garcia et al., 1998) . The Cdc25 domain is responsible for the Ras-specific GEF activity of SOS1, whereas the DH domain is necessary for the Rac1-specific GEF activity of the protein (Bar-Sagi, 1994; Das et al., 2000; Scita et al., 2001) . The REM domain is important for an allosteric interaction between SOS1 and Ras-GTP, which induces the activation of the Cdc25 domain (Margarit et al., 2003) . The proline-rich C-terminal region of SOS1 interacts with growth factor receptor bound protein 2 (Grb2) (Bar-Sagi, 1994) . The Grb2-SOS1 complex mediates the stimulation of the RasErk1/2 pathway by ligand-activated RTKs (Lowenstein et al., 1992) .
CIIA was initially discovered as an anti-apoptotic protein that turned out to be identical to VPS28 (Cho et al., 2003; Kim et al., 2010) . Aside from these initial findings, we have recently shown that CIIA physically associates with SOS1 and promotes the SOS1-mediated activation of Rac1 (Hwang et al., 2011) . We now report that CIIA, by binding SOS1, inhibits the GEF activity of SOS1 on Ras. Our results suggest that CIIA functions as a negative switch of the SOS1-Ras signaling events initiated by RTK-coupled peptide growth factors.
RESULTS AND DISCUSSION
CIIA inhibits the activation of the SOS1-Ras-Erk1/2 signaling events induced by peptide growth factors
As we reported previously (Hwang et al., 2011) , coimmunoprecipitation analysis revealed that CIIA physically associates with SOS1 in NIH3T3 cells ( Fig. 1A ; supplementary material Fig. S1A ). This interaction was enhanced after the cells were exposed to peptide growth factors, including epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF).
Next, given that many peptide growth factors stimulate the tyrosine kinase activities of their specific receptors and thereby facilitate the SOS1-Ras signaling processes, we examined the possible effects of CIIA on Ras and Erk1/2 activation initiated by peptide growth factors. After stably transfecting NIH3T3 cells or PC12 cells with either an empty plasmid vector or a vector for hemagglutinin (HA)-tagged CIIA or FLAG-tagged CIIA, we treated those cells with the indicated peptide growth factors and then examined the activities of Ras and Erk1/2 in the cells. Ras activation was monitored by binding of active Ras (Ras-GTP) to a GST-fused Raf fragment containing the Ras-GTP-binding domain (GST-RBD), and Erk1/2 activation was detected by immunoblotting with antibodies to phosphorylated Erk1/2. Ectopic CIIA dramatically suppressed the activation of Ras and Erk1/2 induced by EGF, PDGF, FGF or nerve growth factor (NGF) ( Fig. 1B-E ; supplementary material Fig. S1B-E) . Next, in order to examine the effect of endogenous CIIA on Ras and Erk1/2 activities, we constructed HeLa cells expressing either small interfering RNA (siRNA) against GFP (siGFP) or CIIA siRNA (siCIIA). siRNA-mediated depletion of CIIA expression potentiated the EGF-induced activation of both Ras and Erk1/2 activities, and this effect was reversed by ectopic expression of Myc-tagged CIIA* (which contains three silent point mutations within the region targeted by the CIIA siRNA) ( Fig. 1F ; supplementary material Fig. S1F ). Moreover, siRNA-mediated 
CIIA blocks Ras activation by inhibiting the Ras-GEF activity of SOS1
We previously observed that CIIA binds to the central region of SOS1 (SOS1-CEN; amino acid residues 551-1050) (Hwang et al., 2011) , which is involved in Ras activation (Chardin et al., 1993) . We, therefore, examined the effect of siCIIA on the interaction between SOS1 and Ras in HeLa cells. siRNA-mediated depletion of CIIA enhanced the interaction between SOS1 and Ras ( Fig Fig. S2C ). Next, given that SOS1-CEN possesses the Ras-specific GEF activity (Corbalan-Garcia et al., 1998), we examined the effect of CIIA on Ras activation induced by SOS1-CEN. In a Ras-GEF assay, the fluorescence intensity increased when SOS1-CEN was added to GST-Ras, and this increase was reduced by CIIA ( Fig. 2C ), indicating that CIIA inhibited the GEF activity of SOS1-CEN on Ras. Taken together, these results suggest that CIIA inhibits the SOS1-Ras interaction and the GEF activity of SOS1 on Ras, thereby suppressing SOS1-mediated Ras activation. By contrast, CIIA did not affect the interaction between ectopic SOS1 and Grb2 in HEK293T cells ( Fig. 2D ; supplementary material Fig. S2D ) or the interaction between endogenous SOS1 and Grb2 in MDCK cells (supplementary material Fig. S2C ). siRNA-mediated depletion of CIIA also did not affect either the binding between Grb2 and SOS1 under basal conditions, or the EGF-induced dissociation of SOS1 and Grb2 ( Fig. 2E ; supplementary material Fig. S2E ).
CIIA inhibits EGF-induced cyclin D1 expression and DNA synthesis
The peptide-growth-factor-stimulated Erk1/2 pathway mediates cyclin D1 induction and DNA synthesis (Cheng et al., 1998) .
Indeed, EGF treatment increased the abundance of cyclin D1 transcript ( Fig. 3A) and protein ( Fig. 3B ) in siGFP-expressing HeLa cells. This effect of EGF was inhibited by U0126 (Fig. 3A,B) , which is a MEK1 inhibitor that can block EGFinduced Erk1/2 activation (supplementary material Fig. S3 ). Thus, our results suggest that EGF induces cyclin D1 expression through stimulation of the Erk1/2 pathway. Furthermore, siRNAmediated depletion of CIIA potentiated the EGF-induced cyclin D1 expression in siCIIA-expressing HeLa cells (Fig. 3A,B) . Next, we examined the effect of CIIA on EGF-induced DNA synthesis in cultured cells. DNA synthesis analysis using a 59-bromo-29deoxyuridine (BrdU) incorporation assay revealed that EGF induced DNA synthesis in siGFP-expressing HeLa cells, and that this effect was inhibited by PD98059 (Fig. 3C) , which is another MEK1 inhibitor that blocks EGF-induced Erk1/2 activation (supplementary material Fig. S3 ). siRNAmediated depletion of CIIA expression enhanced EGF-induced DNA synthesis in HeLa cells (Fig. 3C) . Consistently, ectopic expression of CIIA in MDCK cells abrogated EGF-induced DNA synthesis (Fig. 3D) . These results suggest that CIIA blocks cyclin D1 expression, as well as DNA synthesis, induced by EGFstimulated Erk1/2 pathway.
CIIA fails to inhibit Ras and Erk1/2 activation mediated by Noonan-syndrome-associated SOS1 mutants
Next, we examined whether CIIA could regulate the function of the Noonan-syndrome-associated mutants of SOS1. We chose four Noonan-syndrome-associated SOS1 mutants (M269R, R552G, W729L and E846K), whose mutations are located within the DH, helical linker (HL), REM and Cdc25 domains, respectively. These SOS1 mutants appear to lose the autoinhibitory regulation of the Ras-GEF activity (Robert et al., 2007; Sondermann et al., 2004; Tartaglia et al., 2007) . We transfected 293T cells with a vector encoding the indicated SOS1 variant and then examined the binding of CIIA to each of the SOS1 variants. CIIA was able to bind M269R, R552G, W729L and E846K mutants of SOS1 as well as wild-type SOS1 in the cells ( Fig. 4A ; supplementary material Fig. S4C ). Next, we examined whether CIIA could affect the binding of the SOS1 variants to Ras. CIIA failed to inhibit the binding between Ras and each of the four mutants of SOS1, whereas it blocked the binding between Ras and wild-type SOS1 ( Fig. 4B ; supplementary material Fig. S4D ). Furthermore, CIIA did not affect the EGF-induced activation of Ras and Erk1/2 mediated by the SOS1 W729L (Fig. 4C) , E846K (Fig. 4D ), M269R (supplementary material Fig. S4E ) or R552G mutants (supplementary material Fig. S4F ). The GEF assay data also showed that CIIA did not inhibit the Ras-GEF activity of SOS-CEN (W729L) (Fig. 4E) , unlike its inhibition on the Ras-GEF activity of SOS-CEN (Fig. 2C ). In addition, CIIA failed to inhibit EGF-induced DNA synthesis mediated by SOS1 W729L or SOS1 E846K (Fig. 4F) . Collectively, these results suggest that the Noonan-syndrome-associated SOS1 mutants are resistant to the inhibitory action of CIIA on the Ras-GEF activity, although the molecular mechanism of this is not clear yet. Given that the SOS1 mutants used in the present study are known to lose the autoinhibitory regulation of the Ras-GEF activity (Robert et al., 2007) , it would be intriguing to investigate whether CIIA promotes the autoinhibitory regulation of the SOS1 Ras-GEF activity. Moreover, our findings suggest that malfunction of CIIA could cause misregulation of the SOS1-Ras signaling pathway, thereby leading to abnormality in various cellular events, including cell proliferation. Fig. 1 . CIIA inhibits the activation of Ras and Erk1/2 induced by peptide growth factors. (A) NIH3T3 cells were incubated in the absence or presence of EGF (100 ng/ml), PDGF (20 ng/ml) or FGF (10 ng/ml) for 5 min. Cell lysates were subjected to immunoprecipitation (IP) with rabbit anti-CIIA antibody or rabbit preimmune IgG, and the resulting precipitates were immunoblotted (IB) with anti-SOS1 antibody. (B-E) NIH 3T3/neo and NIH 3T3/HA-CIIA cells (B-D) or PC12/control and PC12/Flag-CIIA cells (E) were serum-starved for 16 h and then were left untreated or treated with EGF (100 ng/ml) (B), FGF (10 ng/ml) (C) or PDGF (20 ng/ml) (D) for 5 min, or with NGF (100 ng/ml) for 10 min (E). Cell lysates were subjected to pull-down (PD) with glutathione-agarose beads coupled to GST-RBD. Bead-bound proteins were immunoblotted with anti-Ras antibody. Cell lysates were also immunoblotted with antibodies to phosphorylated Erk1/2 (indicated by the P within a circle), Erk1/2, Ras or HA. (F,G) HeLa cells expressing siGFP, siCIIA or siCIIA plus CIIA*-Myc (F), or siGFP, siSOS1 or siCIIA plus siSOS (G), were serum-starved for 16 h, then incubated for 5 min without or with EGF (100 ng/ml). Cell lysates were assayed for Ras activity as in B. Cell lysates were also immunoblotted with the indicated antibodies. Ras pulldown and Erk1/2 phosphorylation data in B-G were quantified and the means6s.d. from two or three independent experiments are shown in supplementary material Fig. S1B -G, respectively. The intensities of the bands were determined by densitometry and expressed as the fold increase as shown underneath the blots. 
MATERIALS AND METHODS
Cell culture, transfection and antibodies 293T, MDCK, NIH3T3 and HeLa cells were maintained under a humidified atmosphere of 5% CO 2 at 37˚C in Dulbecco's modified Eagle's medium (DMEM; Hyclone, South Logan, UT) supplemented with 10% fetal bovine serum (FBS; Hyclone). PC12 cells were cultured in DMEM containing 10% FBS and 5% horse serum (Invitrogen) on culture dishes coated with poly-Dlysine (Sigma). MDCK and PC12 cells were stably transfected with either pcDNA3-puro/Flag-CIIA or an empty vector, and were selected with puromycin. NIH3T3 cells were stably transfected with either pcDNA3/HA-CIIA or an empty vector, and selected with G418. HeLa cells were stably transfected with pSUPER.retro/siGFP or pSUPER.retro/siCIIA, and were selected with puromycin. Rabbit polyclonal antibodies to CIIA, to SOS1 and to Grb2 were from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal antibodies to Ras and to cyclin D were purchased from BD Biosciences (Franklin Lakes, NJ) and from Santa Cruz Biotechnology, respectively. Mouse monoclonal antibodies to Flag and to HA were obtained from Sigma-Aldrich (St Louis, MO). Rabbit polyclonal antibodies to Erk1/2 and to phosphorylated Erk1/2 were from Cell Signaling (Beverly, MA).
Co-immunoprecipitation
Cells were lysed in NETN lysis buffer and subjected to coimmunprecipitation as described previously (Hwang et al., 2011) .
In vitro small-GTP-binding protein activity assay
Cell lysates were subjected to centrifugation at 12,000 g at 4˚C, and the supernatants were subjected to pull-down with GST-Raf (RBD)-coupled glutathione-agarose beads. Ras-GTP in the pull-down precipitates was examined by immunoblotting analysis with anti-Ras antibody.
In vitro GEF assay
In vitro GEF activity of SOS1 variants was examined with a GEF exchange assay biochem kit (Cytoskeleton Inc.), as described previously (Hwang et al., 2011) .
BrdU incorporation assay
Cells were incubated with 10 mM BrdU for 6 h, and analyzed for BrdU incorporation with a cell proliferation ELISA kit (Roche Applied Science, Indianapolis, IN). Data are the mean6s.d. of quadruplicate samples from four representative experiments.
Semi-quantitative RT-PCR
Total RNA was extracted from cultured cells using RNeasy Mini kit (Qiagen, Valencia, CA). RT-PCR analysis was performed with primers to cyclin D1 or to glyceraldehyde-3-phosphate dehydrogenase as a control. D) . Then, the cells were serumstarved for 16 h, and incubated with 100 ng/ml EGF for indicated times. Cell lysates were examined for Ras activity by GST pull-down assay. The cell lysates were also immunoblotted with antibodies against phosphorylated Erk1/2 (indicated by the P within a circle), Erk1/2, Ras, Flag or HA. The intensities of the bands were determined by densitometry and expressed as the fold increase as shown underneath the blots. (E) The GEF activity of SOS1-CEN (W729L) on Ras was determined in vitro in the absence or presence of CIIA by fluorescence spectroscopy with a GEF exchange assay kit. Left: relative fluorescence intensity data from one representative experiment. Right: data are the means6s.d. of three independent experiments. Results are expressed as the N9-methylanthraniloyl-GTP (mant-GTP) incorporation into GST-Ras after 600 s relative to time 0 after adding SOS1-CEN (W729L). *P,0.01, N.S., not significant. (F) Hela cells were transfected for 30 h with plasmid vectors encoding the indicated proteins. Cells were then serum-starved for 16 h, and incubated for 6 h without or with 100 ng/ml EGF. Then, the cells were treated with 10 uM BrdU for 4 h and assayed for BrdU incorporation. Data are the means6s.d. of three independent experiments.
